Bruce Bigelow joins Xconomy from the business desk of the San Diego Union-Tribune. He was a member of the team of reporters who were awarded the 2006 Pulitzer Prize in National Reporting for uncovering bribes paid to San Diego Republican Rep. Randy “Duke” Cunningham in exchange for special legislation earmarks. He also shared a 2006 award for enterprise reporting from the Society of Business Editors and Writers for “In Harm’s Way,” an article about the extraordinary casualty rate among employees working in Iraq for San Diego’s Titan Corp. He has written extensively about the 2002 corporate accounting scandal at software goliath Peregrine Systems. He also was a Gerald Loeb Award finalist and National Headline Award winner for “The Toymaker,” a 14-part chronicle of a San Diego start-up company. He takes special satisfaction, though, that the series was included in the library for nonfiction narrative journalism at the Nieman Foundation for Journalism at Harvard University.
Bigelow graduated from U.C. Berkeley in 1977 with a degree in English Literature and from the Columbia University Graduate School of Journalism in 1979. Before joining the Union-Tribune in 1990, he worked for the Associated Press in Los Angeles and The Kansas City Times.
Helen Torley, who was highlighted in 2016 as the only female CEO of a public life sciences company in San Diego, was recognized last week for her operational excellence at... Read more »
CureMatch, a San Diego startup with technology to help doctors choose the best combination of anti-cancer treatments based on an analysis of each patient’s tumor, took home a $35,000 grant... Read more »
Teradata (NYSE: TDC), a specialist in data warehousing, business analytics, and consulting services, disclosed this week that it plans to move its corporate headquarters from Dayton, OH, to San Diego... Read more »
Awarepoint, the San Diego healthtech startup that specialized in real-time location systems for tracking medical equipment and people in hospitals and clinics, has gone 404.
That’s the error code message that... Read more »
In the weeks since Escient Pharmaceuticals made its debut, the San Diego biotech has found lab space atop San Diego’s Torrey Pines Mesa and is recruiting scientists with experience developing drugs... Read more »
The San Diego RNA drug developer Arcturus Therapeutics (NASDAQ: ARCT) on Thursday reinstated fired CEO Joseph Payne and named ResMed (NYSE: RMD) founder Peter Farrell as chairman of the... Read more »
The debut Wednesday of Dynam.AI, a San Diego startup offering its expertise in artificial intelligence, also marks a shift that has been underway for the past year or so at Analytics... Read more »
The San Diego RNA drug developer Arcturus Therapeutics (NASDAQ: ARCT) named four new board members Tuesday, after the four directors who fired founding CEO Joseph Payne resigned as part of... Read more »
A few years before the presidential election of 2016, with all its Wikileaks, Russian disinformation campaigns, and phony Facebook links, San Diego’s Mitek Systems (NASDAQ: MITK made a strategic decision to... Read more »
Bloom Science, a biotech founded to advance a new class of microbe-based therapeutics for neurological disorders, is making its debut today with the publication of research that suggests certain bacteria... Read more »
It’s been a busy year for Jerusalem-based Mobileye since Intel (NASDAQ: INTC) completed its $15.3-billion acquisition of the Israeli specialist in autonomous navigation technology.
In a recent update, Mobileye co-founder... Read more »
After establishing a partnership with the Google Cloud Platform, Zesty.io CEO Gerry Widmer said Wednesday the San Diego-based company is expanding its workforce and extending its Web content management system (WCMS)... Read more »
With the Bio-IT World Conference opening today in Boston, San Diego-based Illumina (NASDAQ: ILMN) said it has acquired Edico Genome, a five-year-old startup with technology to accelerate the readout of... Read more »
At the end of the 19th century, the German scientist Paul Ehrlich began to realize that certain chemicals could have highly specific effects on certain diseases. He began to write about... Read more »
The temperature in California’s Palm Desert hit 107 degrees Tuesday, but indoors at Intel Capital’s Global Summit meeting, the corporate venture arm said it has invested a cool $115 million so... Read more »
San Diego’s Histogen, a regenerative medicine company with technology for using nascent skin cells to produce “cosmeceutical” products, says the FDA has given a green light to its application for an... Read more »
© 2007-2018, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.